Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen - 42 Year Stock Price History | AMGN

Historical daily share price chart and data for Amgen since 1983 adjusted for splits and dividends. The latest closing stock price for Amgen as of April 25, 2025 is 280.84.
  • The all-time high Amgen stock closing price was 332.02 on September 20, 2024.
  • The Amgen 52-week high stock price is 346.85, which is 23.5% above the current share price.
  • The Amgen 52-week low stock price is 253.30, which is 9.8% below the current share price.
  • The average Amgen stock price for the last 52 weeks is 304.96.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amgen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 292.7949 257.2020 327.3600 256.5180 280.8400 8.62%
2024 295.8508 286.3540 332.0210 254.9770 258.5510 -6.77%
2023 236.8725 243.5010 277.7560 203.0640 277.3320 13.46%
2022 226.0444 204.5060 270.2470 199.5080 244.4220 20.43%
2021 205.4106 198.3220 228.4520 179.4180 202.9550 0.89%
2020 199.7703 204.4310 225.2750 156.2680 201.1740 -1.99%
2019 164.3921 158.5690 207.0700 139.5610 205.2570 27.60%
2018 153.3391 142.0820 172.0790 134.3000 160.8580 15.23%
2017 135.2729 117.7000 152.2790 117.7000 139.5940 22.27%
2016 120.3357 120.4800 136.2300 104.8920 114.1700 -7.57%
2015 119.1838 119.2690 133.0770 100.1190 123.5160 3.95%
2014 96.9582 84.7400 128.0340 81.4797 118.8220 42.33%
2013 75.4474 64.0509 86.4943 58.9714 83.4814 34.80%
2012 54.4143 45.1901 64.7838 44.9434 61.9315 36.83%
2011 39.2021 38.7536 45.6342 33.6748 45.2606 18.17%
2010 38.8940 40.2675 42.6534 35.1329 38.3001 -2.95%
2009 38.3106 41.1535 44.9346 31.4703 39.4652 -2.04%
2008 35.6778 32.5098 45.9671 27.8845 40.2884 24.35%
2007 40.4101 47.7182 52.9156 32.3981 32.3981 -32.02%
2006 49.2831 56.0619 56.0619 44.5928 47.6554 -13.38%
2005 48.7988 44.8439 60.1152 39.9047 55.0155 22.93%
2004 41.0910 43.4975 46.2043 36.7653 44.7533 3.82%
2003 42.8662 34.4073 49.9088 34.1004 43.1068 27.82%
2002 34.4574 39.3466 43.5882 21.6755 33.7237 -14.35%
2001 43.4726 43.8638 51.7558 35.9352 39.3745 -11.73%
2000 45.6733 43.9074 54.4155 35.7974 44.6050 6.45%
1999 25.8859 18.7272 45.2590 18.2475 41.9017 129.77%
1998 11.6549 9.4072 18.2911 8.2190 18.2366 93.19%
1997 9.7191 9.5271 11.9252 8.0119 9.4399 -0.46%
1996 10.2046 10.1593 11.4238 8.9820 9.4835 -8.42%
1995 7.1089 5.0797 10.3555 4.9270 10.3555 101.27%
1994 4.2223 4.2839 5.1778 3.0835 5.1451 19.19%
1993 3.6670 6.1588 6.1697 2.7469 4.3166 -29.91%
1992 5.6239 6.5186 6.7802 4.3602 6.1588 -6.77%
1991 3.9397 1.8531 6.6058 1.6787 6.6058 265.06%
1990 1.1483 0.7485 1.8422 0.6504 1.8095 154.11%
1989 0.6373 0.4651 0.8720 0.4633 0.7121 45.18%
1988 0.4445 0.4687 0.5196 0.3743 0.4905 8.88%
1987 0.4686 0.3434 0.6468 0.2361 0.4505 40.91%
1986 0.2940 0.1835 0.4124 0.1817 0.3197 62.95%
1985 0.1115 0.0691 0.2108 0.0673 0.1962 169.88%
1984 0.0798 0.1053 0.1199 0.0527 0.0727 -30.96%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $149.085B $33.424B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $209.613B 16.44
Gilead Sciences (GILD) United States $130.169B 22.68
Vertex Pharmaceuticals (VRTX) United States $125.596B 0.00
Bristol Myers Squibb (BMY) United States $100.171B 43.18
CSL (CSLLY) Australia $74.317B 0.00
GSK (GSK) United Kingdom $74.132B 8.89
Regeneron Pharmaceuticals (REGN) United States $61.567B 14.19
Argenex SE (ARGX) Netherlands $36.226B 250.50
Alnylam Pharmaceuticals (ALNY) United States $30.513B 0.00
BioNTech SE (BNTX) Germany $23.700B 0.00
BeiGene (ONC) Cayman Islands $22.837B 0.00
Biogen (BIIB) United States $17.362B 7.20
Genmab (GMAB) Denmark $13.262B 16.16
Genmab (GNMSF) Denmark $13.255B 13.66
Insmed (INSM) United States $13.209B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.290B 21.75
Illumina (ILMN) United States $11.268B 29.06
Incyte (INCY) United States $11.265B 342.41
Ascendis Pharma (ASND) Denmark $10.063B 0.00
Exelixis (EXEL) United States $9.973B 20.68
Swedish Orphan Biovitrum (BIOVF) Sweden $9.612B 24.55
Moderna (MRNA) United States $9.555B 0.00
QIAGEN (QGEN) Netherlands $9.049B 18.21
Exact Sciences (EXAS) United States $7.724B 0.00
Bio-Techne Corp (TECH) United States $7.604B 29.15
Repligen (RGEN) United States $7.299B 87.84
Halozyme Therapeutics (HALO) United States $7.263B 15.00
Roivant Sciences (ROIV) United Kingdom $7.243B 0.00
Revolution Medicines (RVMD) United States $6.834B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.311B 21.85
Jazz Pharmaceuticals (JAZZ) Ireland $6.242B 5.64
Legend Biotech (LEGN) United States $6.024B 0.00
TG Therapeutics (TGTX) United States $6.019B 273.71
Telix Pharmaceuticals (TLX) Australia $5.646B 0.00
Guardant Health (GH) United States $5.550B 0.00
Blueprint Medicines (BPMC) United States $5.412B 0.00
Sarepta Therapeutics (SRPT) United States $5.219B 24.56
Nuvalent (NUVL) United States $5.129B 0.00
Axsome Therapeutics (AXSM) United States $5.094B 0.00
ADMA Biologics Inc (ADMA) United States $5.037B 42.62
Verona Pharma American Depositary Share (VRNA) United Kingdom $5.007B 0.00
Krystal Biotech (KRYS) United States $4.871B 50.77
Cytokinetics (CYTK) United States $4.706B 0.00
Zealand Pharma (ZLDPF) Denmark $4.604B 0.00
Alkermes (ALKS) Ireland $4.451B 11.16
Vaxcyte (PCVX) United States $3.947B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.903B 0.00
PTC Therapeutics (PTCT) United States $3.738B 0.00
Arcellx (ACLX) United States $3.408B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.351B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.262B 0.00
Avidity Biosciences (RNA) United States $3.205B 0.00
Zai Lab (ZLAB) China $3.162B 0.00
Akero Therapeutics (AKRO) United States $2.996B 0.00
Merus (MRUS) Netherlands $2.975B 0.00
Scholar Rock Holding (SRRK) United States $2.917B 0.00
SpringWorks Therapeutics (SWTX) United States $2.842B 0.00
Protagonist Therapeutics (PTGX) United States $2.841B 11.02
Viking Therapeutics (VKTX) United States $2.688B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.687B 0.00
Immunovant (IMVT) United States $2.573B 0.00
Alvotech (ALVO) Luxembourg $2.499B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.457B 21.99
MoonLake Immunotherapeutics (MLTX) Switzerland $2.453B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.399B 0.00
Certara (CERT) United States $2.285B 48.79
Apellis Pharmaceuticals (APLS) United States $2.284B 0.00
Twist Bioscience (TWST) United States $2.195B 0.00
ImmunityBio (IBRX) United States $2.108B 0.00
Amicus Therapeutics (FOLD) United States $2.098B 113.83
Biohaven (BHVN) United States $2.079B 0.00
Vericel (VCEL) United States $2.067B 229.06
Metsera (MTSR) United States $2.056B 0.00
Ligand Pharmaceuticals (LGND) United States $2.021B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.934B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.890B 0.00
Denali Therapeutics (DNLI) United States $1.850B 0.00
Belite Bio (BLTE) United States $1.796B 0.00
Bavarian Nordic (BVNRY) Denmark $1.793B 12.63
Janux Therapeutics (JANX) United States $1.755B 0.00
NovoCure (NVCR) Jersey $1.712B 0.00
Beam Therapeutics (BEAM) United States $1.696B 0.00
Kymera Therapeutics (KYMR) United States $1.687B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.632B 11.34
Ascentage Pharma Group - (AAPG) China $1.630B 0.00
Agios Pharmaceuticals (AGIO) United States $1.585B 0.00
CG Oncology (CGON) United States $1.573B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.543B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.543B 0.00
ANI Pharmaceuticals (ANIP) United States $1.507B 17.05
IDEAYA Biosciences (IDYA) United States $1.495B 0.00
Apogee Therapeutics (APGE) United States $1.491B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.468B 0.00
Disc Medicine (IRON) United States $1.458B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.421B 0.00
Edgewise Therapeutics (EWTX) United States $1.409B 0.00
MannKind (MNKD) United States $1.379B 28.38
Mesoblast (MESO) Australia $1.362B 0.00
Vera Therapeutics (VERA) United States $1.357B 0.00
Travere Therapeutics (TVTX) United States $1.324B 0.00
Dynavax Technologies (DVAX) United States $1.279B 57.28
Structure Therapeutics (GPCR) United States $1.248B 0.00
NeoGenomics (NEO) United States $1.229B 0.00
Celldex Therapeutics (CLDX) United States $1.215B 0.00
Liquidia Technologies (LQDA) United States $1.170B 0.00
Pacira BioSciences (PCRX) United States $1.141B 10.72
Adaptive Biotechnologies (ADPT) United States $1.089B 0.00
Viridian Therapeutics (VRDN) United States $1.070B 0.00
BGM Group (BGM) China $1.070B 0.00
Iovance Biotherapeutics (IOVA) United States $1.003B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.993B 0.00
MiMedx (MDXG) United States $0.984B 23.03
Novavax (NVAX) United States $0.965B 0.00
GRAIL (GRAL) United States $0.953B 0.00
Anbio Biotechnology (NNNN) Germany $0.951B 0.00
WAVE Life Sciences (WVE) Singapore $0.909B 0.00
89BIO (ETNB) United States $0.885B 0.00
Mineralys Therapeutics (MLYS) United States $0.866B 0.00
Gyre Therapeutics (GYRE) United States $0.831B 111.00
Arcus Biosciences (RCUS) United States $0.828B 0.00
Geron (GERN) United States $0.809B 0.00
Zymeworks (ZYME) United States $0.802B 0.00
Oculis Holding AG (OCS) Switzerland $0.798B 0.00
Nurix Therapeutics (NRIX) United States $0.781B 0.00
Spyre Therapeutics (SYRE) United States $0.764B 0.00
Anavex Life Sciences (AVXL) United States $0.761B 0.00
Vir Biotechnology (VIR) United States $0.754B 0.00
Intellia Therapeutics (NTLA) United States $0.748B 0.00
Pharvaris (PHVS) Netherlands $0.732B 0.00
AbCellera Biologics (ABCL) Canada $0.721B 0.00
Myriad Genetics (MYGN) United States $0.704B 0.00
UniQure (QURE) Netherlands $0.703B 0.00
CureVac (CVAC) Germany $0.700B 3.80
Day One Biopharmaceuticals (DAWN) United States $0.693B 0.00
Immunome (IMNM) United States $0.688B 0.00
Praxis Precision Medicines (PRAX) United States $0.681B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.675B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.672B 0.00
Nuvation Bio (NUVB) United States $0.667B 0.00
Bicara Therapeutics (BCAX) United States $0.663B 0.00
LENZ Therapeutics (LENZ) United States $0.656B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
AnaptysBio (ANAB) United States $0.630B 0.00
Dianthus Therapeutics (DNTH) United States $0.626B 0.00
Castle Biosciences (CSTL) United States $0.620B 34.69
ArriVent BioPharma (AVBP) United States $0.617B 0.00
Replimune (REPL) United States $0.616B 0.00
Pharming Group (PHGUF) Netherlands $0.604B 0.00
Arbutus Biopharma (ABUS) United States $0.603B 0.00
Arvinas (ARVN) United States $0.591B 0.00
Trevi Therapeutics (TRVI) United States $0.587B 0.00
Keros Therapeutics (KROS) United States $0.571B 0.00
Pharming Group (PHAR) Netherlands $0.550B 0.00
Niagen Bioscience (NAGE) United States $0.526B 169.00
Opthea (OPT) Australia $0.525B 0.00
Immatics (IMTX) Germany $0.518B 30.43
Bicycle Therapeutics (BCYC) United Kingdom $0.511B 0.00
CorMedix Inc (CRMD) United States $0.500B 0.00
Cogent Biosciences (COGT) United States $0.498B 0.00
Prothena (PRTA) Ireland $0.495B 0.00
Northwest Biotherapeutics (NWBO) United States $0.493B 0.00
Sionna Therapeutics (SION) United States $0.488B 0.00
Fortrea Holdings (FTRE) United States $0.477B 15.56
Kura Oncology (KURA) United States $0.477B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.474B 0.00
Tyra Biosciences (TYRA) United States $0.474B 0.00
GH Research (GHRS) Ireland $0.473B 0.00
Upstream Bio (UPB) United States $0.471B 0.00
Cytek Biosciences (CTKB) United States $0.468B 0.00
Cullinan Therapeutics (CGEM) United States $0.462B 0.00
Sage Therapeutics (SAGE) United States $0.457B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.456B 0.00
Urogen Pharma (URGN) United States $0.446B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.436B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.435B 0.00
MeiraGTx Holdings (MGTX) United States $0.427B 0.00
Stoke Therapeutics (STOK) United States $0.416B 0.00
Precigen (PGEN) United States $0.409B 0.00
Abivax SA (ABVX) France $0.406B 0.00
PureTech Health (PRTC) United States $0.402B 0.00
Absci (ABSI) United States $0.394B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.390B 0.00
Celcuity (CELC) United States $0.387B 0.00
Eton Pharmaceuticals (ETON) United States $0.385B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.381B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.379B 0.00
Kamada (KMDA) Israel $0.374B 25.00
Zenas BioPharma (ZBIO) United States $0.373B 0.00
Sana Biotechnology (SANA) United States $0.371B 0.00
Rapport Therapeutics (RAPP) United States $0.370B 0.00
Maze Therapeutics (MAZE) United States $0.368B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.366B 0.00
Oric Pharmaceuticals (ORIC) United States $0.339B 0.00
Checkpoint Therapeutics (CKPT) United States $0.338B 0.00
Erasca (ERAS) United States $0.329B 0.00
Benitec Biopharma (BNTC) United States $0.322B 0.00
Tectonic Therapeutic (TECX) United States $0.318B 0.00
Allogene Therapeutics (ALLO) United States $0.315B 0.00
Alpha Teknova (TKNO) United States $0.308B 0.00
Entrada Therapeutics (TRDA) United States $0.306B 4.26
Olema Pharmaceuticals (OLMA) United States $0.302B 0.00
REGENXBIO (RGNX) United States $0.298B 0.00
Verastem (VSTM) United States $0.296B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.286B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.281B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.280B 0.00
MaxCyte (MXCT) United States $0.277B 0.00
ATyr Pharma (ATYR) United States $0.275B 0.00
Cartesian Therapeutics (RNAC) United States $0.272B 0.00
Aura Biosciences (AURA) United States $0.269B 0.00
Palvella Therapeutics (PVLA) United States $0.268B 0.00
Septerna (SEPN) United States $0.262B 0.00
2seventy Bio (TSVT) United States $0.261B 0.00
Humacyte (HUMA) United States $0.261B 0.00
MBX Biosciences (MBX) United States $0.255B 0.00
Atea Pharmaceuticals (AVIR) United States $0.254B 0.00
XOMA Royalty (XOMA) United States $0.253B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.253B 0.00
Emergent Biosolutions (EBS) United States $0.251B 0.00
ITeos Therapeutics (ITOS) United States $0.249B 0.00
Monopar Therapeutics (MNPR) United States $0.242B 0.00
Compass Therapeutics (CMPX) United States $0.242B 0.00
Lifecore Biomedical (LFCR) United States $0.237B 0.00
Abeona Therapeutics (ABEO) United States $0.236B 0.00
Alumis (ALMS) United States $0.236B 0.00
Bright Minds Biosciences (DRUG) United States $0.233B 0.00
Third Harmonic Bio (THRD) United States $0.233B 0.00
Astria Therapeutics (ATXS) United States $0.228B 0.00
Prima BioMed (IMMP) Australia $0.225B 0.00
ACELYRIN, INC (SLRN) United States $0.222B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.221B 0.00
Candel Therapeutics (CADL) United States $0.216B 0.00
CARGO Therapeutics (CRGX) United States $0.214B 0.00
Adocia (ADOCY) France $0.213B 0.00
Cidara Therapeutics (CDTX) United States $0.213B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.212B 0.00
Foghorn Therapeutics (FHTX) United States $0.211B 0.00
Terns Pharmaceuticals (TERN) United States $0.210B 0.00
Nuvectis Pharma (NVCT) United States $0.207B 0.00
EnGene Holdings (ENGN) Canada $0.204B 0.00
BioStem Technologies (BSEM) $0.203B 8.11
Anika Therapeutics (ANIK) United States $0.199B 0.00
Design Therapeutics (DSGN) United States $0.199B 0.00
Ocugen (OCGN) United States $0.198B 0.00
Solid Biosciences (SLDB) United States $0.198B 0.00
Gossamer Bio (GOSS) United States $0.191B 0.00
Cardiff Oncology (CRDF) United States $0.190B 0.00
Amarin (AMRN) Ireland $0.187B 0.00
TuHURA Biosciences (HURA) United States $0.181B 0.00
Semper Paratus Acquisition (TVGN) United States $0.180B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.179B 0.00
Fulcrum Therapeutics (FULC) United States $0.178B 0.00
Inventiva S.A (IVA) France $0.176B 0.00
GENFIT S.A (GNFT) France $0.175B 0.00
Codexis (CDXS) United States $0.175B 0.00
Voyager Therapeutics (VYGR) United States $0.174B 0.00
Neurogene (NGNE) United States $0.172B 0.00
INmune Bio (INMB) United States $0.168B 0.00
Rezolute (RZLT) United States $0.166B 0.00
Inhibrx Biosciences (INBX) United States $0.166B 0.00
Innate Pharma S.A (IPHA) France $0.165B 0.00
DBV Technologies S.A (DBVT) France $0.164B 0.00
Prime Medicine (PRME) United States $0.163B 0.00
Molecular Partners AG (MOLN) Switzerland $0.160B 0.00
Annexon (ANNX) United States $0.160B 0.00
Sangamo Therapeutics (SGMO) United States $0.159B 0.00
Actuate Therapeutics (ACTU) United States $0.156B 0.00
Aardvark Therapeutics (AARD) United States $0.152B 0.00
DiaMedica Therapeutics (DMAC) United States $0.152B 0.00
Kodiak Sciences (KOD) United States $0.150B 0.00
AC Immune (ACIU) Switzerland $0.149B 0.00
Puma Biotechnology (PBYI) United States $0.142B 4.69
Adherex Technologies (FENC) United States $0.140B 0.00
Tango Therapeutics (TNGX) United States $0.139B 0.00
BioAge Labs (BIOA) United States $0.139B 0.00
Compugen (CGEN) Israel $0.131B 0.00
Coherus BioSciences (CHRS) United States $0.130B 0.00
ScPharmaceuticals (SCPH) United States $0.129B 0.00
Nkarta (NKTX) United States $0.128B 0.00
Fate Therapeutics (FATE) United States $0.127B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.126B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.125B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.120B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.120B 0.00
Contineum Therapeutics (CTNM) United States $0.120B 0.00
Galena Biopharma (SLS) United States $0.119B 0.00
Greenwich LifeSciences (GLSI) United States $0.119B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.118B 0.00
Seer (SEER) United States $0.118B 0.00
Theratechnologies (THTX) Canada $0.116B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.109B 0.00
Editas Medicine (EDIT) United States $0.107B 0.00
Neumora Therapeutics (NMRA) United States $0.105B 0.00
Rapt Therapeutics (RAPT) United States $0.104B 0.00
Cuprina Holdings (Cayman) (CUPR) $0.104B 0.00
Instil Bio (TIL) United States $0.101B 0.00
Senti Biosciences (SNTI) United States $0.101B 0.00
Nautilus Biotechnology (NAUT) United States $0.096B 0.00
Elutia (ELUT) United States $0.095B 0.00
Immunic (IMUX) United States $0.094B 0.00
BioHarvest Sciences (BHST) Canada $0.093B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.093B 0.00
Alector (ALEC) United States $0.091B 0.00
Genelux (GNLX) United States $0.091B 0.00
EXoZymes (EXOZ) United States $0.091B 0.00
XBiotech (XBIT) United States $0.090B 0.00
Pliant Therapeutics (PLRX) United States $0.090B 0.00
C4 Therapeutics (CCCC) United States $0.089B 0.00
Coya Therapeutics (COYA) United States $0.088B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.088B 0.00
CervoMed (CRVO) United States $0.085B 0.00
Climb Bio (CLYM) United States $0.085B 0.00
HilleVax (HLVX) United States $0.085B 0.00
Zura Bio (ZURA) United States $0.084B 0.00
Vigil Neuroscience (VIGL) United States $0.084B 0.00
Black Diamond Therapeutics (BDTX) United States $0.082B 0.00
TScan Therapeutics (TCRX) United States $0.081B 0.00
Entera Bio (ENTX) Israel $0.081B 0.00
Vor Biopharma (VOR) $0.081B 0.00
Cellectis S.A (CLLS) France $0.081B 0.00
Kyverna Therapeutics (KYTX) United States $0.080B 0.00
Aerovate Therapeutics (AVTE) United States $0.080B 0.00
Ventyx Biosciences (VTYX) United States $0.076B 0.00
Elicio Therapeutics (ELTX) United States $0.076B 0.00
IGM Biosciences (IGMS) United States $0.073B 0.00
Adagene (ADAG) China $0.072B 0.00
InflaRx (IFRX) Germany $0.071B 0.00
MediciNova (MNOV) United States $0.071B 0.00
Genenta Science S.p.A (GNTA) Italy $0.071B 0.00
I-Mab (IMAB) United States $0.069B 0.00
Caribou Biosciences (CRBU) United States $0.068B 0.00
Sagimet Biosciences (SGMT) United States $0.068B 0.00
Rani Therapeutics Holdings (RANI) United States $0.067B 0.00
Clearside Biomedical (CLSD) United States $0.066B 0.00
Alpha Cognition (ACOG) Canada $0.066B 0.00
Seres Therapeutics (MCRB) United States $0.065B 0.00
Inovio Pharmaceuticals (INO) United States $0.064B 0.00
Biomea Fusion (BMEA) United States $0.064B 0.00
Adlai Nortye (ANL) Cayman Islands $0.063B 0.00
VTv Therapeutics (VTVT) United States $0.063B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.061B 0.00
Adverum Biotechnologies (ADVM) United States $0.061B 0.00
Alto Neuroscience (ANRO) United States $0.061B 0.00
Invivyd (IVVD) United States $0.061B 0.00
VistaGen Therapeutics (VTGN) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
ZIVO Bioscience (ZIVO) United States $0.061B 0.00
Jasper Therapeutics (JSPR) United States $0.060B 0.00
Inozyme Pharma (INZY) United States $0.059B 0.00
IO Biotech (IOBT) Denmark $0.057B 0.00
Renovaro (RENB) United States $0.056B 0.00
Cabaletta Bio (CABA) United States $0.056B 0.00
Artiva Biotherapeutics (ARTV) United States $0.055B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.055B 0.00
Kronos Bio (KRON) United States $0.054B 0.00
Akoya Biosciences (AKYA) United States $0.054B 0.00
Medicus Pharma (MDCX) United States $0.054B 0.00
Ikena Oncology (IKNA) United States $0.054B 0.00
Exicure (XCUR) United States $0.053B 0.00
Precision BioSciences (DTIL) United States $0.053B 0.00
BeyondSpring (BYSI) United States $0.053B 0.00
Agenus (AGEN) United States $0.053B 0.00
CytomX Therapeutics (CTMX) United States $0.053B 1.73
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.052B 0.00
Repare Therapeutics (RPTX) Canada $0.051B 0.00
PDS Biotechnology (PDSB) United States $0.049B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.049B 0.00
Oncolytics Biotech (ONCY) Canada $0.048B 0.00
Forte Biosciences (FBRX) United States $0.048B 0.00
Citius Oncology (CTOR) United States $0.048B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.047B 0.00
Applied Therapeutics (APLT) United States $0.047B 0.00
Cue Biopharma (CUE) United States $0.047B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.047B 0.00
Oncobiologics (OTLK) United States $0.046B 0.00
Immuneering (IMRX) United States $0.046B 0.00
Immix Biopharma (IMMX) United States $0.045B 0.00
Fortress Biotech (FBIO) United States $0.045B 0.00
FibroBiologics (FBLG) United States $0.045B 0.00
Skye Bioscience (SKYE) United States $0.044B 0.00
Sutro Biopharma (STRO) United States $0.044B 0.00
Mersana Therapeutics (MRSN) United States $0.044B 0.00
Quince Therapeutics (QNCX) United States $0.044B 0.00
Adicet Bio (ACET) United States $0.043B 0.00
PepGen (PEPG) United States $0.043B 0.00
Spero Therapeutics (SPRO) United States $0.042B 0.00
Scilex Holding (SCLX) United States $0.042B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.042B 0.00
OKYO Pharma (OKYO) $0.041B 0.00
Werewolf Therapeutics (HOWL) United States $0.041B 0.00
Connect Biopharma Holdings (CNTB) United States $0.041B 0.00
Bluebird Bio (BLUE) United States $0.041B 0.00
CAMP4 Therapeutics (CAMP) United States $0.040B 0.00
Tenaya Therapeutics (TNYA) United States $0.039B 0.00
Advanced Biomed (ADVB) United States $0.039B 0.00
Xilio Therapeutics (XLO) United States $0.039B 0.00
OnKure Therapeutics (OKUR) United States $0.039B 0.00
Whitehawk Therapeutics (WHWK) United States $0.039B 0.00
AN2 Therapeutics (ANTX) United States $0.038B 0.00
TELA Bio (TELA) United States $0.038B 0.00
Rein Therapeutics (RNTX) United States $0.037B 0.00
RenovoRx (RNXT) United States $0.037B 0.00
Shattuck Labs (STTK) United States $0.037B 0.00
Celularity (CELU) United States $0.037B 0.00
Dyadic (DYAI) United States $0.037B 0.00
Lantern Pharma (LTRN) United States $0.037B 0.00
Atara Biotherapeutics (ATRA) United States $0.036B 0.00
Kalaris Therapeutics (KLRS) United States $0.035B 0.00
Opus Genetics (IRD) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
Femasys (FEMY) United States $0.034B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.034B 0.00
X4 Pharmaceuticals (XFOR) United States $0.033B 0.00
Radiopharm Theranostics - (RADX) Australia $0.032B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.032B 0.00
Boundless Bio (BOLD) United States $0.032B 0.00
Cadrenal Therapeutics (CVKD) United States $0.031B 0.00
Alterity Therapeutics - (ATHE) Australia $0.031B 0.00
Kezar Life Sciences (KZR) United States $0.030B 0.00
Allakos (ALLK) United States $0.029B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.029B 0.00
ALX Oncology Holdings (ALXO) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Estrella Immunopharma (ESLA) United States $0.029B 0.00
Aligos Therapeutics (ALGS) United States $0.029B 0.00
Pluri (PLUR) Israel $0.028B 0.00
Intensity Therapeutics (INTS) United States $0.028B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.028B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.028B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.027B 0.00
Generation Bio (GBIO) United States $0.026B 0.00
Cara Therapeutics (TVRD) United States $0.026B 0.00
Q32 Bio (QTTB) United States $0.026B 0.00
Clene (CLNN) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
Lexaria Bioscience (LEXX) Canada $0.024B 0.00
Cognition Therapeutics (CGTX) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
KALA BIO (KALA) United States $0.022B 0.00
Tenax Therapeutics (TENX) United States $0.022B 0.00
Longeveron (LGVN) United States $0.022B 0.00
Grace Therapeutics (GRCE) Canada $0.021B 0.00
CalciMedica (CALC) United States $0.021B 0.00
Promis Neurosciences (PMN) Canada $0.021B 0.00
Ovid Therapeutics (OVID) United States $0.021B 0.00
Passage Bio (PASG) United States $0.021B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.020B 0.00
Lisata Therapeutics (LSTA) United States $0.019B 0.00
BioAtla (BCAB) United States $0.019B 0.00
Annovis Bio (ANVS) United States $0.017B 0.00
Equillium (EQ) United States $0.017B 0.00
Cingulate (CING) United States $0.017B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Enzo Biochem (ENZ) United States $0.016B 0.00
UNITY Biotechnology (UBX) United States $0.016B 0.00
Chemomab Therapeutics (CMMB) Israel $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
BRIACELL THERAP (BCTX) Canada $0.016B 0.00
Edesa Biotech (EDSA) Canada $0.016B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.016B 0.00
Leap Therapeutics (LPTX) United States $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.014B 0.00
ABVC BioPharma (ABVC) United States $0.013B 0.00
Bolt Biotherapeutics (BOLT) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Cocrystal Pharma (COCP) United States $0.013B 0.00
SAB Biotherapeutics (SABS) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
IN8bio (INAB) United States $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
LakeShore Biopharma (LSB) China $0.013B 0.00
Synlogic (SYBX) United States $0.012B 0.00
Moleculin Biotech (MBRX) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Quantum Biopharma (QNTM) Canada $0.012B 0.00
Affimed (AFMD) Germany $0.012B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Curis (CRIS) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Rallybio (RLYB) United States $0.010B 0.00
Hoth Therapeutics (HOTH) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
NextCure (NXTC) United States $0.010B 0.00
BioXcel Therapeutics (BTAI) United States $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Athira Pharma (ATHA) United States $0.009B 0.00
HOOKIPA Pharma (HOOK) United States $0.009B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.009B 0.00
BioCardia (BCDA) United States $0.009B 0.00
COSCIENS Biopharma (CSCI) Canada $0.009B 0.00
IBio (IBIO) United States $0.009B 0.00
Gelteq (GELS) Australia $0.009B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Aprea Therapeutics (APRE) United States $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Dogwood Therapeutics (DWTX) United States $0.008B 0.00
HCW Biologics (HCWB) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Ocean Biomedical (OCEA) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
MetaVia (MTVA) United States $0.006B 0.00
Aytu BioPharma (AYTU) United States $0.006B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.006B 0.00
Soligenix (SNGX) United States $0.005B 0.00
Evogene (EVGN) Israel $0.005B 0.00
Spruce Biosciences (SPRB) United States $0.005B 0.00
NuCana (NCNA) United Kingdom $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Arcadia Biosciences (RKDA) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Novogen (KZIA) Australia $0.003B 0.00
Galecto (GLTO) Denmark $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Organovo Holdings (ONVO) United States $0.003B 0.00
Ensysce Biosciences (ENSC) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Tharimmune (THAR) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Evaxion Biotech (EVAX) Denmark $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Eyenovia (EYEN) United States $0.002B 0.00
Polyrizon (PLRZ) Israel $0.001B 0.00
Vincerx Pharma (VINC) United States $0.001B 0.00
NAYA Biosciences (NAYA) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.001B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00